Norges Bank’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Norges Bank’s Portfolio OMED Stock Details OMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-182,357	Closed	-$190K	–	2174
2019 Q1	$190K	Hold	182,357	–	–	﹤0.01%	2100
2018 Q4	$136K	Hold	182,357	–	–	﹤0.01%	2107
2018 Q3	$387K	Hold	182,357	–	–	﹤0.01%	2107
2018 Q2	$421K	Hold	182,357	–	–	﹤0.01%	2097
2018 Q1	$580K	Hold	182,357	–	–	﹤0.01%	2088
2017 Q4	$748K	Hold	182,357	–	–	﹤0.01%	2079
2017 Q3	$824K	Hold	182,357	–	–	﹤0.01%	2078
2017 Q2	$607K	Hold	182,357	–	–	﹤0.01%	2075
2017 Q1	$1.68M	Hold	182,357	–	–	﹤0.01%	2010
2016 Q4	$1.41M	Hold	182,357	–	–	﹤0.01%	1999
2016 Q3	$1.99M	Hold	182,357	–	–	﹤0.01%	1979
2016 Q2	$2.25M	Hold	182,357	–	–	﹤0.01%	1992
2016 Q1	$1.84M	Hold	182,357	–	–	﹤0.01%	2001
2015 Q4	$4.11M	Hold	182,357	–	–	﹤0.01%	1908
2015 Q3	$3.02M	Hold	182,357	–	–	﹤0.01%	1972
2015 Q2	$4.1M	Hold	182,357	–	–	﹤0.01%	1932
2015 Q1	$4.7M	Hold	182,357	–	–	﹤0.01%	1919
2014 Q4	$3.97M	Buy	+182,357	New	+$3.74M	﹤0.01%	1973

Norges Bank's OMED Position: Q2 2019 in Review

Norges Bank sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q2 2019, closing a stake of 182,357 shares — an estimated $190K sold.

Norges Bank first reported a position in OMED in Q4 2014 and held it in 18 quarters. The position peaked at $4.7M in Q1 2015. 0 funds tracked by Wall St. Rank hold OMED as of Q2 2019.

Norges Bank reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
Norges Bank sold 182,357 OncoMed Pharmaceuticals, Inc. shares in Q2 2019, an estimated $190K.
Norges Bank first reported a position in OncoMed Pharmaceuticals, Inc. in Q4 2014 and held it in 18 quarters.
Norges Bank's OncoMed Pharmaceuticals, Inc. position peaked at $4.7M in Q1 2015.
0 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q2 2019.

Based on Norges Bank's 13F filing for Q2 2019, filed 9 Aug 2019.